BDBM261353 6-(4-(2-((2,6-difluorobenzyl)oxy)-1,1,1,3,3,3-hexafluoropropan-2-yl)phenyl)-6-((4-fluorophenyl)sulfonyl)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-amine::US9708253, 11

SMILES Fc1ccc(cc1)S(=O)(=O)C1(CCC(=O)C(Br)C1)c1ccc(cc1)C(OCc1c(F)cccc1F)(C(F)(F)F)C(F)(F)F

InChI Key InChIKey=OBVGYENTMGJPQD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 261353   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM261353(6-(4-(2-((2,6-difluorobenzyl)oxy)-1,1,1,3,3,3-hexa...)
Affinity DataIC50:  3.39E+3nMT: 2°CAssay Description:The binding of potential ligands to RORγ is measured by competition with [3H]25-hydroxycholesterol (Perkin Elmer NET674250UC) using a scintillat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent